Skip to main content

Table 1 Characteristic of the included studies

From: Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis

literature

patient races

study design

Ding H, 2005 [8]

Asian

randomized controlled study with description of withdrawals and dropouts

Zhang Q, 2009 [9]

Asian

randomized controlled study with description of withdrawals and dropouts

 

88% Asian

 

Leung N, 2009 [10]

12% non-Asian

randomized controlled study with description of withdrawals and dropouts

Yang F, 2010 [11]

Asian

randomized controlled study with description of withdrawals and dropouts

Zou S, 2010 [12]

Asian

randomized controlled study with description of withdrawals and dropouts

Huang H, 2010 [13]

Asian

randomized controlled study with description of withdrawals and dropouts